TRADING UPDATES: Belvoir, Ingenta revenue up; Symphony revenue down
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Read moreFri, 18th Jun 2021 08:52
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Read moreTuesday 26 July | |
Aberforth Smaller Companies Trust PLC | Half Year Results |
Ascential PLC | Half Year Results |
Bytes Technology Group PLC | Trading Statement |
Capital & Counties Properties PLC | Half Year Results |
Cohort PLC | Full Year Results |
Compass Group PLC | Trading Statement |
Dotdigital Group PLC | Trading Statement |
Drax Group PLC | Half Year Results |
easyJet PLC | Trading Statement |
Ergomed PLC | Trading Statement |
Franchise Brands PLC | Half Year Results |
Games Workshop Group PLC | Full Year Results |
Gore Street Energy Storage Fund PLC | Full Year Results |
Greencore Group PLC | Q3 Results |
John Menzies PLC | Trading Statement |
Medica Group PLC | Trading Statement |
Mitie Group PLC | Trading Statement |
NewRiver REIT PLC | Trading Statement |
Playtech PLC | Trading Statement |
Reach PLC | Half Year Results |
Ricardo PLC | Trading Statement |
Sabre Insurance Group PLC | Half Year Results |
SME Credit Realisation Fund Ltd | Full Year Results |
Trifast PLC | Full Year Results |
Tyman PLC | Half Year Results |
Unilever PLC | Half Year Results |
Vivo Energy PLC | Half Year Results |
Wickes Group PLC | Trading Statement |
Wednesday 27 July | |
Aptitude Software Group PLC | Half Year Results |
BlackRock Energy & Resources Income Trust PLC | Half Year Results |
Breedon Group PLC | Half Year Results |
British American Tobacco PLC | Half Year Results |
FirstGroup PLC | Trading Statement |
Fresnillo PLC | Q2 Production Results |
GSK PLC | Half Year Results |
Hargreaves Services PLC | Full Year Results |
Hiscox Ltd | Trading Statement |
Ibstock PLC | Half Year Results |
International Personal Finance PLC | Half Year Results |
Lancashire Holdings Ltd | Half Year Results |
Lloyds Banking Group PLC | Half Year Results |
Marston's PLC | Trading Statement |
Motorpoint Group PLC | Trading Statement |
musicMagpie PLC | Half Year Results |
Nichols PLC | Half Year Results |
Primary Health Properties PLC | Half Year Results |
Quartix Technologies PLC | Half Year Results |
Reckitt Benckiser Group PLC | Half Year Results |
Rio Tinto PLC | Half Year Results |
Smart Metering Systems PLC | Half Year Results |
Smurfit Kappa Group PLC | Half Year Results |
Ted Baker PLC | Trading Statement |
Unite Group PLC | Half Year Results |
Wizz Air Holdings PLC | Q1 Results |
Yourgene Health PLC | Full Year Results |
Thursday 28 July | |
Airtel Africa PLC | Trading Statement |
Anglo American PLC | Half Year Results |
Aveva Group PLC | Trading Statement |
BAE Systems PLC | Half Year Results |
Barclays PLC | Half Year Results |
Bodycote PLC | Half Year Results |
BT Group PLC | Q1 Results |
Centrica PLC | Half Year Results |
CVS Group PLC | Trading Statement |
De La Rue PLC | Trading Statement |
Diageo PLC | Full Year Results |
discoverIE Group PLC | Trading Statement |
Dr Martens PLC | Trading Statement |
Elementis PLC | Half Year Results |
FDM Group PLC | Half Year Results |
Forterra PLC | Half Year Results |
Foxtons Group PLC | Half Year Results |
GB Group PLC | Trading Statement |
Greencoat UK Wind PLC | Half Year Results |
Hammerson PLC | Half Year Results |
Headlam Group PLC | Trading Statement |
Inchcape PLC | Half Year Results |
Indivior PLC | Half Year Results |
Informa PLC | Half Year Results |
ITV PLC | Half Year Results |
Jupiter Fund Management PLC | Half Year Results |
Logistics Development Group PLC | Trading Statement |
Metro Bank PLC | Half Year Results |
Mitchells & Butlers PLC | Trading Statement |
Mortgage Advice Bureau (Holdings) PLC | Trading Statement |
Mothercare PLC | Full Year Results |
MySale Group PLC | Trading Statement |
National Express Group PLC | Half Year Results |
Quixant PLC | Trading Statement |
Rathbones Group PLC | Half Year Results |
Relx PLC | Half Year Results |
Rentokil Initial PLC | Half Year Results |
Restore PLC | Half Year Results |
Robert Walters PLC | Half Year Results |
Schroders PLC | Half Year Results |
Segro PLC | Half Year Results |
Shell PLC | Half Year Results |
Smith & Nephew PLC | Half Year Results |
St James's Place PLC | Half Year Results |
Vesuvius PLC | Half Year Results |
Volex PLC | Half Year Results |
Weir Group PLC | Half Year Results |
Friday 29 July | |
Allianz Technology Trust PLC | Half Year Results |
Aston Martin Lagonda Global Holdings PLC | Half Year Results |
AstraZeneca PLC | Half Year Results |
Babcock International Group PLC | Full Year Results |
CMC Markets PLC | Trading Statement |
Croda International PLC | Half Year Results |
Glencore PLC | Trading Statement |
IMI PLC | Half Year Results |
Impellam Group PLC | Half Year Results |
Industrials REIT Ltd | Trading Statement |
International Consolidated Airlines Group SA | Half Year Results |
Intertek Group PLC | Half Year Results |
Law Debenture Corp PLC | Half Year Results |
Morgan Advanced Materials PLC | Half Year Results |
NatWest Group PLC | Half Year Results |
Premier Miton Global Renewables Trust PLC | Half Year Results |
Rightmove PLC | Half Year Results |
Shearwater Group PLC | Full Year Results |
Standard Chartered PLC | Half Year Results |
Walker Crips Group PLC | Full Year Results |
YouGov PLC | Trading Statement |
Monday 1 August | |
Ascential PLC | Half Year Results |
Cranswick PLC | Q1 Results |
Dialight PLC | Half Year Results |
GlobalData PLC | Half Year Results |
HSBC Holdings PLC | Half Year Results |
Hutchmed (China) Ltd | Half Year Results |
NAHL Group PLC | Trading Statement |
Pearson PLC | Half Year Results |
Spectris PLC | Half Year Results |
Copyright 2022 Alliance News Limited. All Rights Reserved. |
Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - Begins phase I trial of HMPL-A83 for patients with advanced malignant neoplasms, in China. HMPL-A83 is an investigational novel IgG4-type humanized anti-CD47 monoclonal antibody. Malignant neoplasms are cancerous tumours. It has "significant" potential to be used as a combination therapy with Hutchmed's existing portfolio, the firm says.
Read moreHutchmed China Ltd - Hong Kong-based biopharmaceutical company - Presents positive results from the Savannah phase two trial of Hutchmed and AstraZeneca PLC's savolitinib in combination with Astra's osimertinib in epidermal growth factor receptor-mutated non-small cell lung cancer patients.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Read more(Alliance News) - Hutchmed China Ltd on Wednesday announced the first patient has been dosed for its phase I trial for IMG-007.
Read moreHutchmed China Ltd - Hong Kong-based biopharmaceutical company - Receives approval for Tazverik from the Health Commission & Medical Products Administration of the Hainan province in China. The approval is for use in the Hainan pilot zone under the Clinically Urgently Needed Imported Drugs scheme, for the treatment of certain patients with epithelioid sarcoma and follicular lymphoma.
Read more(Alliance News) - Stock prices in London were lower at midday on Tuesday following the long bank holiday weekend in the UK, as markets globally prepare for a sharp US interest rate hike and similar moves by other central banks as they struggle to control inflation.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read moreHutchmed (China) Ltd - Hong Kong-based biopharmaceuticals - The US Food & Drug Administration has rejected Hutchmed's surufatinib for treatment of pancreatic neuroendocrine tumours. In a complete response letter, the FDA says the current data package, based on two positive phase three trials in China and one bridging study in the US, does not support an approval in the US "at this time". The FDA said a multi-regional clinical trial of surufatinib required for US approval. Surufatinib was approved in China for the treatment of pNETs and extra-pancreatic neuroendocrine tumours in June 2021 and December 2020, respectively. Chief Executive Officer & Chief Scientific Officer Weiguo Su comments: "Although this decision from the FDA is disappointing, we remain confident about the clinical value of surufatinib for NET patients and committed to making surufatinib available to patients globally. We look forward to working with the agency to evaluate its feedback."
Read more(Alliance News) - Stock prices in London opened lower on Tuesday following the long bank holiday weekend, with BP shares rising as the oil major planned to return cash to shareholders amid calls by some UK politicians for a windfall profit tax on energy companies.
Read more(Alliance News) - Stock prices in London are seen opening lower on Tuesday, after the long bank holiday weekend in the UK, as concerns rise over aggressive monetary policy tightening by the US Federal Reserve.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
Read moreThursday 21 April | |
Alliance Trust PLC | AGM |
Ibstock PLC | AGM |
Journeo PLC | AGM |
Relx PLC | AGM |
STV Group PLC | AGM |
Ruffer Investment Co Ltd | EGM re share issue |
Friday 22 April | |
Bellevue Healthcare Trust PLC | AGM |
Faron Pharmaceuticals Ltd | AGM |
Murray International Trust PLC | AGM |
Monday 25 April | |
Belluscura PLC | AGM |
Capital Gearing Trust PLC | GM re non pre-emptive share issue |
Cloudbreak Discovery PLC | GM re Crescita equity drawdown agreement |
Hikma Pharmaceuticals PLC | AGM |
JPMorgan US Smaller Cos Investment Trust PLC | AGM |
Polymetal International PLC | AGM |
Symphony International Holdings Ltd | AGM |
Tuesday 26 April | |
Aquis Exchange PLC | AGM |
Elementis PLC | AGM |
GlobalData PLC | AGM |
Oriole Resources PLC | AGM |
RPS Group PLC | AGM |
SigmaRoc PLC | AGM |
Taylor Wimpey PLC | AGM |
Tissue Regenix Group PLC | AGM |
Wednesday 27 April | |
Drax Group PLC | AGM |
EP Global Opportunities Trust PLC | AGM |
Global Invacom Group Ltd | AGM |
Hutchmed (China) Ltd | AGM |
London Stock Exchange Group PLC | AGM |
McKay Securities PLC | GM re Workspace offer |
Nichols PLC | AGM |
Persimmon PLC | AGM |
Primary Health Properties PLC | AGM |
VH Global Sustainable Energy Opportunities PLC | AGM |
Copyright 2022 Alliance News Limited. All Rights Reserved. |
Hutchmed China Ltd - Hong Kong-based biopharmaceutical company - US Securities & Exchange Commission identifies Hutchmed China under the new Holding Foreign Companies Accountable Act, which identifies public companies who have used auditors from overseas or auditors who are unable to be investigated completely. The new regulation has no impact on business operations, Hutchmed says.
Read more